2-112159829-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_153214.3(FBLN7):c.229C>T(p.Leu77Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000595 in 1,545,644 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_153214.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FBLN7 | NM_153214.3 | c.229C>T | p.Leu77Phe | missense_variant | 2/8 | ENST00000331203.7 | NP_694946.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FBLN7 | ENST00000331203.7 | c.229C>T | p.Leu77Phe | missense_variant | 2/8 | 1 | NM_153214.3 | ENSP00000331411 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000657 AC: 10AN: 152210Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000136 AC: 21AN: 154006Hom.: 0 AF XY: 0.000108 AC XY: 9AN XY: 83490
GnomAD4 exome AF: 0.0000589 AC: 82AN: 1393316Hom.: 0 Cov.: 30 AF XY: 0.0000639 AC XY: 44AN XY: 688654
GnomAD4 genome AF: 0.0000656 AC: 10AN: 152328Hom.: 0 Cov.: 33 AF XY: 0.0000671 AC XY: 5AN XY: 74486
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 07, 2022 | The c.229C>T (p.L77F) alteration is located in exon 2 (coding exon 2) of the FBLN7 gene. This alteration results from a C to T substitution at nucleotide position 229, causing the leucine (L) at amino acid position 77 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at